Our data revealed highly frequent mutations in ryanodine receptors (RYRs) - RYR1, RYR2, and RYR3 in ESCC patients, out of which several were truncating mutations (Figure 2A, S3A). This evidence concerns the gene RYR2 and esophageal squamous cell carcinoma.